This is a standard procedural filing. Traders should monitor for any unexpected developments during the actual shareholder meeting, but no immediate market reaction is expected based on this document.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Mar 19 $70.35entry
- T+1 · 8mo ago −1.04%α +0.70% · $69.62
- T+5 · 8mo ago +1.65%α +3.86% · $71.51
- T+20 · 7mo ago +6.13%α −1.49% · $74.66
- T+60 · 5mo ago −7.94%α −22.28% · $64.76
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
GE HealthCare Technologies Inc. has filed its 2026 Definitive Proxy Statement (DEFA14A), which outlines the agenda for its upcoming annual shareholder meeting. The primary items on the agenda include the election of eight director nominees, an advisory vote on executive compensation, and the ratification of Deloitte & Touche LLP as the independent auditor for 2026. This is a routine annual filing with no material financial data or unexpected corporate actions disclosed.
Key Facts
- The filing is a routine annual proxy statement for the 2026 Annual Meeting.
- The main agenda items are the election of 8 director nominees, an advisory vote on executive compensation, and the ratification of the independent auditor.
- No new financial information, strategic changes, or material corporate actions were announced in the filing.
Financial Impact
No immediate financial impact.
Risk Factors
- The advisory vote on executive compensation could be a point of contention, though it is non-binding.
- The election of directors is a standard governance matter, but a significant number of votes against a nominee could signal shareholder dissatisfaction.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001932393-26-000023 |
| Document: 0001932393-26-000023-index-headers.html | 0001932393-26-000023 |
| Document: 0001932393-26-000023-index.html | 0001932393-26-000023 |
| Document: 0001932393-26-000023.txt | 0001932393-26-000023 |
Track record
13 reports on GEHC
2 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +19.07% at T+20 after the Oct 19, 2026 report. 2 of 3 went positive at some point.
Filters
- Nov 5, 202611d ago 8-K Neutral 3/10 Entry $83.75 to $81.84 Now $82.96 −0.94% ▼ −2.28% −5.57% vs SPY
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $83.75 to $81.84 Now $82.96 −0.94% ▼ −2.28% −5.57% vs SPY
- Oct 28, 202619d ago 8-K Bullish 6/10 Entry $75.82 to $85.81 Now $82.96 +9.42% ▲ +13.18% +13.89% vs SPY
- Oct 19, 202628d ago Institutional Cluster Bullish 4/10 Entry $69.72 to $71.60 Now $82.96 +18.99% ▲ +2.70% +2.84% vs SPY
- Sep 22, 20267w ago 8-K Neutral 2/10 Entry $66.09 to $65.37 Now $82.96 +25.53% ▼ −1.09% −0.41% vs SPY
- Sep 16, 20268w ago 3 Neutral 2/10 Entry $64.45 to $66.38 Now $82.96 +28.73% ▲ +3.00% +2.40% vs SPY
- Jul 29, 202615w ago 8-K Neutral 2/10 Entry $71.90 to $70.24 Now $82.96 +15.38% ▼ −2.31% −7.84% vs SPY
- May 13, 202626w ago Insider Cluster Neutral 2/10 Entry $64.26 to $62.86 Now $82.96 +29.10% ▼ −2.18% −3.98% vs SPY
- May 11, 202627w ago 8-K Neutral 2/10 Entry $62.29 to $61.51 Now $82.96 +33.18% ▼ −1.25% −1.33% vs SPY
- Apr 30, 202628w ago Insider Cluster Neutral 4/10 Entry $60.96 to $63.40 Now $82.96 +36.09% ▲ +4.00% +1.64% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers